Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
47.46
-2.14 (-4.31%)
Mar 6, 2026, 12:45 PM EST - Market open
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Phibro Animal Health stock have an average target of 34.33, with a low estimate of 26 and a high estimate of 50. The average target predicts a decrease of -27.66% from the current stock price of 47.46.
Analyst Consensus: Hold
* Price targets were last updated on Nov 7, 2025.
Analyst Ratings
The average analyst rating for Phibro Animal Health stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +5.36% | Nov 7, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $19 → $27 | Sell | Maintains | $19 → $27 | -43.10% | Aug 29, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $25 → $35 | Hold → Buy | Upgrades | $25 → $35 | -26.25% | Jul 7, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $26 | Hold | Maintains | $21 → $26 | -45.21% | Jun 25, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | -55.75% | May 8, 2025 |
Financial Forecast
Revenue This Year
1.52B
from 1.30B
Increased by 17.03%
Revenue Next Year
1.58B
from 1.52B
Increased by 3.82%
EPS This Year
3.09
from 1.19
Increased by 159.29%
EPS Next Year
3.43
from 3.09
Increased by 11.24%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.6B | 1.6B | |
| Avg | 1.5B | 1.6B | |
| Low | 1.4B | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.4% | 7.4% | |
| Avg | 17.0% | 3.8% | |
| Low | 11.6% | -1.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.23 | 3.62 | |
| Avg | 3.09 | 3.43 | |
| Low | 2.91 | 3.14 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 171.8% | 17.4% | |
| Avg | 159.3% | 11.2% | |
| Low | 144.6% | 1.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.